Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDIA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AHNAK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNPH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
WWTR1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TH2LCRR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM53A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF771 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01554 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AHSG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP11B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPLP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on